182 related articles for article (PubMed ID: 37921845)
1. Utility of G protein-coupled oestrogen receptor 1 as a biomarker for pan-cancer diagnosis, prognosis and immune infiltration: a comprehensive bioinformatics analysis.
Fan YC; Wu W; Leng XF; Zhang HW
Aging (Albany NY); 2023 Nov; 15(21):12021-12067. PubMed ID: 37921845
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance and oncogenic function of NR1H4 in clear cell renal cell carcinoma.
Huang S; Hou Y; Hu M; Hu J; Liu X
BMC Cancer; 2022 Sep; 22(1):995. PubMed ID: 36123627
[TBL] [Abstract][Full Text] [Related]
3. Pan-cancer analysis reveals correlation between RAB3B expression and tumor heterogeneity, immune microenvironment, and prognosis in multiple cancers.
Liu XS; Chen YL; Chen YX; Wu RM; Tan F; Wang YL; Liu ZY; Gao Y; Pei ZJ
Sci Rep; 2024 Apr; 14(1):9881. PubMed ID: 38688977
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic, Prognostic, and Immunological Roles of HELLS in Pan-Cancer: A Bioinformatics Analysis.
Liang X; Li L; Fan Y
Front Immunol; 2022; 13():870726. PubMed ID: 35774795
[TBL] [Abstract][Full Text] [Related]
5. The gene expression of GPER1 is low in fresh samples of papillary thyroid carcinoma (PTC), and in silico analysis.
Bertoni APS; Manfroi PA; Tomedi J; Assis-Brasil BM; de Souza Meyer EL; Furlanetto TW
Mol Cell Endocrinol; 2021 Sep; 535():111397. PubMed ID: 34273443
[TBL] [Abstract][Full Text] [Related]
6. ORC6, a novel prognostic biomarker, correlates with T regulatory cell infiltration in prostate adenocarcinoma: a pan-cancer analysis.
Lin Y; Zhang Y; Tuo Z; Gao L; Ding D; Bi L; Yu D; Lv Z; Wang J; Chen X
BMC Cancer; 2023 Mar; 23(1):285. PubMed ID: 36978046
[TBL] [Abstract][Full Text] [Related]
7. The GPER1/SPOP axis mediates ubiquitination-dependent degradation of ERα to inhibit the growth of breast cancer induced by oestrogen.
Zhang N; Sun P; Xu Y; Li H; Liu H; Wang L; Cao Y; Zhou K; TinghuaiWang
Cancer Lett; 2021 Feb; 498():54-69. PubMed ID: 33069770
[TBL] [Abstract][Full Text] [Related]
8. Cytoplasmic G Protein-Coupled Estrogen Receptor 1 as a Prognostic Indicator of Breast Cancer: A Meta-Analysis.
Zhang D; Wang J; Chen H; Yan S
Technol Cancer Res Treat; 2022; 21():15330338221131664. PubMed ID: 36254557
[No Abstract] [Full Text] [Related]
9. Multi-omics analysis of N6-methyladenosine reader IGF2BP3 as a promising biomarker in pan-cancer.
Chen P; Xu J; Cui Z; Wu S; Xie T; Zhang X
Front Immunol; 2023; 14():1071675. PubMed ID: 36761737
[TBL] [Abstract][Full Text] [Related]
10. NALCN is a potential biomarker and therapeutic target in human cancers.
He J; Xu J; Chang Z; Yan J; Zhang L; Qin Y
Front Genet; 2023; 14():1164707. PubMed ID: 37152978
[No Abstract] [Full Text] [Related]
11. Pan-Cancer Analysis of PDIA3: Identifying It as a Potential Biomarker for Tumor Prognosis and Immunotherapy.
Zhang J; Wang K; Hainisayimu T; Li H
Oxid Med Cell Longev; 2022; 2022():9614819. PubMed ID: 36046686
[TBL] [Abstract][Full Text] [Related]
12. An Integrated Analysis Identified TAGLN2 As an Oncogene Indicator Related to Prognosis and Immunity in Pan-Cancer.
Pan T; Wang S; Wang Z
J Cancer; 2023; 14(10):1809-1836. PubMed ID: 37476180
[No Abstract] [Full Text] [Related]
13. Prognostic Significance and Immunological Role of FBXO5 in Human Cancers: A Systematic Pan-Cancer Analysis.
Liu P; Wang X; Pan L; Han B; He Z
Front Immunol; 2022; 13():901784. PubMed ID: 35720327
[TBL] [Abstract][Full Text] [Related]
14. Correlation between the RNA Expression and the DNA Methylation of Estrogen Receptor Genes in Normal and Malignant Human Tissues.
Rong J; Xie X; Niu Y; Su Z
Curr Issues Mol Biol; 2024 Apr; 46(4):3610-3625. PubMed ID: 38666956
[TBL] [Abstract][Full Text] [Related]
15. F-Box and Leucine-Rich Repeat Protein 7 Is a Prognostic Biomarker and Is Correlated with the Immunosuppressive Microenvironment in Colorectal Cancer.
Wang S; Zhao X; Zhu S; Xu J; Luo T
Genet Test Mol Biomarkers; 2023 Oct; 27(10):325-338. PubMed ID: 37862037
[No Abstract] [Full Text] [Related]
16. Multiomics data identifies RSPO2 as a prognostic biomarker in human tumors associated with pan-cancer.
Srivastava A; Srivastava S
Adv Protein Chem Struct Biol; 2024; 139():469-499. PubMed ID: 38448143
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive bioinformatics analysis of FXR1 across pan-cancer: Unraveling its diagnostic, prognostic, and immunological significance.
Xiao K; Ullah I; Yang F; Wang J; Hou C; Liu Y; Li X
Medicine (Baltimore); 2023 Dec; 102(48):e36456. PubMed ID: 38050239
[TBL] [Abstract][Full Text] [Related]
18. GPC2 Is a Potential Diagnostic, Immunological, and Prognostic Biomarker in Pan-Cancer.
Chen G; Luo D; Zhong N; Li D; Zheng J; Liao H; Li Z; Lin X; Chen Q; Zhang C; Lu Y; Chan YT; Ren Q; Wang N; Feng Y
Front Immunol; 2022; 13():857308. PubMed ID: 35345673
[TBL] [Abstract][Full Text] [Related]
19. A comprehensive prognostic and immune infiltration analysis of EXOC3L1 in pan-cancer.
Zhang ZF
Front Genet; 2022; 13():1044100. PubMed ID: 36479245
[TBL] [Abstract][Full Text] [Related]
20. IMPDH1, a prognostic biomarker and immunotherapy target that correlates with tumor immune microenvironment in pan-cancer and hepatocellular carcinoma.
Liu C; Zhang W; Zhou X; Liu L
Front Immunol; 2022; 13():983490. PubMed ID: 36618420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
